| Literature DB >> 36237524 |
Jiaqi Lu1, Jingyuan Liu1, Liuluan Zhu2,3,4, Yue Zhang2,3,4, Ang Li1.
Abstract
Sepsis is a life-threatening dysregulated host response to infection that compromises organ health, and abdominal sepsis is a commonly presenting critical illness in intensive care units (ICU). In this study, we investigate the effect of age on clinical sepsis characteristics and innate immune cells (neutrophils and monocytes) functionality in abdominal sepsis patients. We recruited 32 patients with abdominal sepsis from the Beijing Ditan Hospital's ICU from February 2021 to September 2021, and selected 18 healthy volunteers that were age- and sex-matched as controls for a prospective cohort study. Elderly abdominal sepsis patients (age >65 years) had the following altered characteristics compared to nonelderly patient controls: lower mean arterial pressure, monocytes percentage, and red blood cell volume distribution width (p < 0.05); higher neutrophils percentage and neutrophils-to-lymphocytes ratio (p < 0.05); significantly increased monocyte-produced reactive oxygen (p < 0.05); increases neutrophilic secretion of TNF-α, as well as lower monocytic secretion of TNF-α (p < 0.05); higher neutrophil percentage (which was significantly higher in peripheral blood than monocyte percentage). Elderly patients also had significantly increased phagocytic activity in their neutrophils and monocytes (p < 0.05), significantly reduced neutrophils-produced reactive oxygen (p < 0.001), and significantly increased TNF-α secretion by monocytes and neutrophils (p < 0.05). We found that elderly patients have decreased immune cell function and increased release of cytokines compared to younger patients, suggesting individualized treatment plans targeting the elderly septic microenvironment could help prevent organ failure in elderly septic patients and improves patient survival.Entities:
Keywords: abdominal infection; age; clinical features; innate immunity; sepsis
Year: 2022 PMID: 36237524 PMCID: PMC9551265 DOI: 10.3389/fphys.2022.952434
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.755
Basic clinical characteristics of patients with abdominal sepsis in different age groups.
| Total ( | Group A (≥65; | Group B (<65; |
| ||
|---|---|---|---|---|---|
| Demographic characteristics | Male (%) | 21 (65.6) | 9 (64.2) | 12 (66.7) | 0.458 |
| Basic disease | Basic diseases (%) | 17 (53.1) | 9 (64.3) | 8 (44.4) | 0.308 |
| Hypertension (%) | 13 (40.6) | 9 (64.3) | 4 (22.2) | 0.149 | |
| Diabetes (%) | 7 (21.9) | 4 (28.6) | 3 (16.7) | 0.669 | |
| CHD (%) | 4 (12.5) | 3 (21.4) | 1 (5.6) | 0.295 | |
| CRF(%) | 6 (18.8) | 4 (28.6) | 2 (11.1) | 0.365 | |
| Operation | Operation (%) | 4 (12.5) | 2 (14.3) | 2 (11.1) | 0.788 |
| Septic shock | Shock (%) | 20 (62.5) | 11 (78.6) | 9 (50.0) | 0.098 |
| SOFA score | SOFA | 6 (5–8) | 6 (4–8) | 6 (5–9) | 0.283 |
| Basic vital signs | Temperature (°C) | 37.5 ± 0.8 | 37.3 ± 0.8 | 37.7 ± 0.7 | 0.106 |
| HR (per minute) | 89 ± 17 | 85 ± 17 | 93 ± 16 | 0.204 | |
| MAP (mmHg) | 67 (60–77) | 60 (56–70) | 73 (64–81) | 0.020 | |
| RR (per minute) | 17 (16–20) | 18 (17–21) | 17 (16–19) | 0.210 | |
| SPO2(%) | 97 (95–99) | 97 (95–98) | 98 (96–99) | 0.465 | |
| Internal environment | PH | 7.45 ± 0.08 | 7.44 ± 0.08 | 7.47 ± 0.08 | 0.287 |
| PCO2(mmHg) | 35 (28–38) | 36 (29–41) | 34 (28–37) | 0.262 | |
| PO2(mmHg) | 105 ± 26 | 106 ± 29 | 104 ± 24 | 0.239 | |
| BE (mmol/L) | 0.8 ± 5.2 | 0.6 ± 4.5 | 1.0 ± 5.9 | 0.852 | |
| HCO3-(mmol/L) | 24.5 ± 4.8 | 24.5 ± 4.1 | 24.5 ± 5.5 | 0.998 | |
| Lactate (mmol/L) | 1.5 (1.0–2.2) | 1.4 (1.0–2.1) | 1.6 (1.1–2.2) | 0.676 | |
| Blood routine index | WBC(109/L) | 10.4 (6.8–16.7) | 11.1 (7.6–14.6) | 10.1 (6.7–18.2) | 0.761 |
| NE (%) | 85.7 (78.7–89.7) | 88.0 (83.1–91.7) | 83.7 (73.3–87.1) | 0.017 | |
| NEUT (109/L) | 8.7 (5.4–14.2) | 9.1 (6.9–13.0) | 7.6 (5.0–15.6) | 0.470 | |
| LY (%) | 7.2 (5.6–9.2) | 6.2 (3.4–8.8) | 7.5 (5.7–13.8) | 0.091 | |
| LYM(109/L) | 0.8 (0.4–1.2) | 0.7 (0.3–1.0) | 0.9 (0.4–1.7) | 0.086 | |
| MO(%) | 6.2 (4.4–10.2) | 5.3 (3.7–7.1) | 8.3 (5.0–13.2) | 0.040 | |
| MONO(109/L) | 0.7 (0.3–1.1) | 0.5 (0.3–1.0) | 0.9 (0.3–1.5) | 0.231 | |
| NLR | 12.24 (8.73–15.65) | 14.07 (9.48–27.40) | 11.38 (5.08–15.18) | 0.003 | |
| NLPR | 12.65 (7.54–21.07) | 14.59 (8.70–24.95) | 10.59 (7.16–16.66) | 0.067 | |
| Hemoglobin (g/L) | 92 ± 27 | 94 ± 23 | 92 ± 31 | 0.836 | |
| HCT (%) | 27.4 ± 7.7 | 27.7 ± 6.5 | 27.1 ± 8.6 | 0.837 | |
| MCV(fl) | 90 ± 9 | 93 ± 7 | 88 ± 10 | 0.177 | |
| MCH(pg) | 30.7 (28.9–32.8) | 30.9 (29.2–32.4) | 30.0 (27.9–33.0) | 0.403 | |
| MCHC(g/l) | 337 ± 17 | 338 ± 12 | 336 ± 21 | 0.845 | |
| RDW (%) | 16.8 (13.7–20.3) | 15.4 (13.1–17.6) | 18.2 (14.3–22.3) | 0.044 |
Note: Group A indicates the cohort of patients aged ≥65 years. Group B indicates the cohort of patients aged <65 years. CHD, coronary heart disease; CRF, chronic renal failure; SOFA, sequential organ failure assessment; HR, heart rate; MAP, mean Arterial pressure; RR, respiratory rate; SPO2, Arterial oxygen saturation; PH, potential of hydrogen; PCO2, partial pressure of carbon dioxide; PO2, oxygen partial pressure; BE, base excess; HCO3 −, bicarbonate radical; WBC, white blood cell count; NE, neutrophil percentage; NEUT, neutrophil count; LY, percentage of lymphocytes; LYM, lymphocyte count; MO, monocyte percentage; MONO, monocyte count; NLR, neutrophil to lymphocyte ratio; NLPR, neutrophil to lymphocyte and platelet ratio; HCT, hematokrit; MCV, mean corpuscular volume; MCH, mean hemoglobin; MCHC, mean hemoglobin concentration; RDW, red blood cell distribution width.
Visceral function measures in abdominal sepsis patients of different age groups.
| Total ( | Group a (≥65; | Group B (<65; |
| ||
|---|---|---|---|---|---|
| Liver function index | TBIL (umol/L) | 27.1 (14.0–92.7) | 15.5 (9.0–32.3) | 60.7 (21.0–117.2) | 0.015 |
| DBIL (umol/L) | 15.4 (7.0–68.7) | 8.0 (6.0–17.1) | 32.9 (13.3–100.1) | 0.019 | |
| Albumin (g/L) | 33.0 ± 4.9 | 34.5 ± 3.5 | 31.9 ± 5.6 | 0.141 | |
| Cholinesterase (U/L) | 2441 (1553–3989) | 2648 (1864–4075) | 2364 (1146–3749) | 0.425 | |
| ALT (U/L) | 34.7 (11.0–71.7) | 22.5 (7.4–68.1) | 38.0 (11.9–108.2) | 0.333 | |
| AST (U/L) | 41.8 (18.6–87.3) | 39.3 (16.3–68.1) | 43.8 (20.5–117.1) | 0.543 | |
| LDH(U/L) | 233.8 (176.6–350.0) | 233.8 (168.3–304.1) | 222.4 (159.4–438.5) | 0.739 | |
| CK(U/L) | 59.5 (29.3–338.2) | 95.2 (36.2–749.2) | 58.0 (22.9–260.1) | 0.257 | |
| Coagulation function index | PLT (109/L) | 105 (66–158) | 140 (75–185) | 97 (58–135) | 0.119 |
| PT(s) | 16.5 (13.2–22.5) | 15.1 (13–21.2) | 18.2 (13.7–23.1) | 0.436 | |
| PTA (%) | 55 ± 21 | 58 ± 23 | 52 ± 19 | 0.478 | |
| APTT(s) | 36.2 (29.2–42.3) | 33.3 (28.7–42.6) | 36.4 (31.8–43.7) | 0.403 | |
| Fib (mg/dl) | 279 (150–420) | 335 (163–457) | 193 (132–338) | 0.087 | |
| INR (%) | 1.5 (1.2–2.0) | 1.4 (1.2–2.0) | 1.7 (1.3–2.0) | 0.436 | |
| FDP (ug/mL) | 11.8 (7.1–24.1) | 11.4 (8.1–16.7) | 13.3 (4.9–49.1) | 0.820 | |
| D - dimer (mg/L) | 3.8 (1.9–11.5) | 3.8 (2.8–6.8) | 4.3 (1.6–18.0) | 0.924 | |
| PT(s) | 17.6 (14.5–19.6) | 17.1 (14.2–19.3) | 18.0 (14.6–19.7) | 0.648 | |
| Renal function index | K+(mmol/L) | 3.8 ± 0.5 | 4.0 ± 0.5 | 141.5 ± 7.0 | 0.097 |
| Na+(mmol/L) | 104.2 ± 6.1 | 138.7 ± 4.3 | 27.1 ± 8.6 | 0.207 | |
| CL−(mmol/L) | 103.5 (100.6–107.9) | 102.5 (99.7–105.8) | 104.7 (101.3–113.3) | 0.210 | |
| Ca2+(mmol/L) | 2.1 ± 0.2 | 2.1 ± 0.2 | 2.1 ± 0.2 | 0.776 | |
| Mg2+(mmol/L) | 1.0 ± 0.2 | 1.0 ± 0.2 | 0.9 ± 0.2 | 0.087 | |
| Carbamide (mmol/L) | 9.8 (6.4–17.2) | 10.0 (5.9–14.4) | 9.8 (6.5–22.4) | 0.470 | |
| Creatinine (umol/L) | 107.0 (69.9–172.6) | 120.7 (62.0–182.8) | 107.0 (70.3–171.1) | 0.790 | |
| Blood Glucose (mmol/L) | 10.5 ± 3.2 | 11.4 ± 3.2 | 9.7 ± 3.2 | 0.148 | |
| AG (mmol/L) | 16.6 ± 4.1 | 16.6 ± 3.4 | 16.6 ± 4.6 | 0.988 | |
| Crystalloid Osmotic Pressure | 301.9 (294.1–310.1) | 300.3 (295.1–307.8) | 304.6 (293.2–314.3) | 0.382 | |
| GFR (ml/min/1.73 m2) | 56.7 (30.9–98.4) | 51.3 (28.4–94.5) | 56.7 (36.8–102.6) | 0.518 | |
| Cardiac function index | BNP(pg/ml) | 478.3 (65.3–770.9) | 250.8 (39.5–1104.0) | 481.7 (81.2–654.8) | 0.896 |
| Myohemoglobin (ng/ml) | 126.7 (89.3–368.4) | 170.3 (88.1–373.3) | 122.6 (96.3–340.1) | 0.868 | |
| TNI(ng/mL) | 0.038 (0.012–0.195) | 0.023 (0.012–0.076) | 0.054 (0.011–12.059) | 0.984 | |
| CK-MB(ng/mL) | 2.1 (0.6–8.1) | 2.4 (0.9–8.1) | 1.9 (0.5–7.5) | 0.510 | |
| Infection index | PCT (ng/mL) | 1.8 (0.5–6.2) | 1.3 (0.6–4.4) | 2.5 (0.4–6.5) | 0.494 |
| CRP (mg/L) | 68.0 (34.1–115.6) | 82 (40.1–118.3) | 49.1 (15.6–108.2) | 0.153 | |
Note: Group A indicates the cohort of patients aged ≥65 years. Group B indicates the cohort of patients aged <65 years. TBIL, total bilirubin; DBIL: direct bilirubin; ALT, alanine transaminase; AST, aspartate Aminotransferase; LDH, lactic dehydrogenase; CK, creatine kinase; PLT, platelet count; PT, prothrombin time; PTA, prothrombin activity; APTT, activated partial thromboplastin time; Fib, Fibrinogen; INR, international normalized ratio; FDP, fibrinogen degradation product; K+, serum kalium; Na+, Natriumion; CL−, chloridion; Ca2+, Calciumion; Mg2+, Magnesiumion; AG, anion gap; GFR, glomerular filtration rate; BNP, B Type Natriuretic Peptide; TNI, Hypersensitive Troponin I; CK-MB, Creative kinase Isoenzyme MB; PCT, procalcitonin; CRP, C-reactive protein.
FIGURE 1Histograms of flow cytometry were applied to represent the functions of the two immune cells. (A) Indicates the phagocytic function of neutrophils. (B) Indicates monocyte phagocytic function. (C) Represents the neutrophil ROS production results. (D) Represents monocyte ROS production results. (E) Represents neutrophil intracellular TNF- α production proportions. (F) Indicates monocytic intracellular TNF- α production proportions. Group A indicates the cohort of patients aged ≥65 years. Group A indicates the cohort of patients aged <65 years. Tumor Necrosis Factor- alpha, TNF-α; Reactive Oxygen Species, ROS.
FIGURE 2Phagocytosis of neutrophils and monocytes in healthy controls and patients with abdominal sepsis of different age groups. Note: (A) Represents the phagocytic function of neutrophils. (B) Represents the phagocytic function of monocytes. Group A indicates the cohort of patients aged ≥65 years. Group A indicates the cohort of patients aged <65 years. We utilize how many of the asterisks indicate the magnitude of the p-value. “****” indicates p < 0.0001.
FIGURE 3ROS production by neutrophils and monocytes in healthy controls and patients with abdominal sepsis of different age groups. Note: (A) Represents ROS of neutrophils. (B) Represents ROS of monocytes. Group A indicates the cohort of patients aged ≥65 years. Group A indicates the cohort of patients aged <65 years. Reactive Oxygen Species, ROS. We utilize how many of the asterisks indicate the magnitude of the p-value. “*” indicates p < 0.05. “****” indicates p < 0.0001.
FIGURE 4Description of ROS generation results by mean fluorescence intensity along with comparison. Note: (A) Represents the mean fluorescence intensity of the results of ROS production by neutrophils. (B) Represents the mean fluorescence intensity of the results for ROS production by monocytes. Group A indicates the cohort of patients aged ≥65 years. Group A indicates the cohort of patients aged <65 years. Reactive Oxygen Species, ROS. We utilize how many of the asterisks indicate the magnitude of the p-value. “****” indicates p < 0.0001.
FIGURE 5TNF-α production from neutrophils and monocytes in healthy controls and patients with abdominal sepsis of different age groups. Note: (A) represents TNF- α secretory function of neutrophils. (B) represents TNF- α secretory function of monocytes. Group A indicates the cohort of patients aged ≥65 years. Group A indicates the cohort of patients aged <65 years. Tumor Necrosis Factor- alpha, TNF-α. We utilize how many of the asterisks indicate the magnitude of the p-value. “*” indicates p < 0.05. “**” indicates p < 0.01. “****” indicates p < 0.0001.
Outcome measures in patients with abdominal sepsis in different age groups.
| Outcome indicator | Total ( | Group A (≥65; | Group B (<65; |
|
|---|---|---|---|---|
| MV(%) | 19 (59.4) | 10 (71.4) | 9 (50.0) | 0.221 |
| AKI(%) | 13 (40.6) | 7 (50.0) | 6 (33.3) | 0.341 |
| RRT (%) | 10 (31.3) | 6 (42.9) | 4 (22.2) | 0.212 |
| Vasoactive agent (%) | 17 (53.1) | 10 (71.4) | 7 (38.9) | 0.087 |
| Superinfection (%) | 8 (25.0) | 4 (28.6) | 4 (22.2) | 0.681 |
| Length of stay (Day) | 32 (16–42) | 40 (19–44) | 25 (11–38) | 0.224 |
| Days in the ICU (Day) | 13 (8–36) | 30 (11–41) | 21 (12–42) | 0.045 |
| 90-day mortality rate(%) | 7 (21.9) | 4 (28.6) | 3 (16.7) | 0.419 |
Note: Group A indicates the cohort of patients aged ≥65 years. Group B indicates the cohort of patients aged <65 years. MV, mechanical ventilation; AKI, acute kidney injury; RRT, renal replacement therapy.